Alphatec
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Alphatec Holdings, Inc. is a medical technology firm dedicated to engineering and advancing solutions for the surgical management of spinal conditions. Its product array includes the Alpha InformatiX ...
Latest News
5 days ago · businesswire.com
ATEC Announces Participation in Upcoming Investor ConferencesCARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conference(s): Management will host one-on-one investor meetings and participate in a fireside chat at Piper Sandler's 38th Annual Healthcare Conference held at the Lotte Hotel in New York on December 1, 2026 at 4:00pm ET. Management will present to inve.
5 days ago · globenewswire.com
Alphatec Holdings, Inc. (NASDAQ: ATEC) INVESTIGATION ALERT: Portnoy Law Firm Announces Investigation into Alphatec Holdings, Inc. Concerning Potential Securities FraudLOS ANGELES, Nov. 11, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm announces that it is investigating potential securities fraud claims on behalf of investors of Alphatec Holdings, Inc. (NASDAQ: ATEC). The investigation concerns whether Alphatec and certain of its officers and directors allegedly engaged in unlawful business practices, made materially false or misleading public statements, or omitted material information necessary to make statements made not misleading.
11 days ago · seekingalpha.com
Alphatec: More Surgeries, Less Revenue Per ProcedureAlphatec Holdings is rated Hold with a $7.80 target, reflecting strong surgical volume growth but declining revenue per procedure and persistent cash flow challenges. Q3 saw 20% more surgeries and 25% more new surgeons, but a 5% drop in revenue per surgery due to weaker biologics sales, impacting overall revenue quality. Gross margin improved to 71.5%, yet margin gains were partly driven by a lower biologics mix, while negative free cash flow and rising debt remain key concerns.
11 days ago · seekingalpha.com
Alphatec: Earnings-Related Selloff Could Provide Another Buying OpportunityIn recent years, Alphatec Holdings has consistently outperformed sales expectations and gained share in the $8 billion U.S. spinal disorder treatment market. However, FY2026 is not playing out as initially expected by management. Last week, Alphatec reported disappointing Q3 results and reduced full-year expectations for revenue, Adjusted EBITDA and free cash flow. Management attributed the shortfall to a combination of execution issues and weakening market trends.
18 days ago · barrons.com
Alphatec Plunges 32%. A Bone-Graft Slump Hits the Spine Specialist's Stock.Alphatec slashes its full-year outlook as fewer surgeons have purchased its add-on bone-graft products used for spinal fusion.
18 days ago · seekingalpha.com
Alphatec Holdings, Inc. (ATEC) Q3 2026 Earnings Call TranscriptAlphatec Holdings, Inc. (ATEC) Q3 2026 Earnings Call Transcript
18 days ago · marketbeat.com
Alphatec Q3 Earnings Call HighlightsAlphatec NASDAQ: ATEC reported third-quarter revenue growth and expanded profitability, while lowering its full-year outlook to reflect weaker biologics performance, softer thoracolumbar procedure volumes and a temporary international supply constraint.
18 days ago · zacks.com
Alphatec (ATEC) Q3 Earnings and Revenues Lag EstimatesAlphatec (ATEC) came out with quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.03 per share a year ago.
28 days ago · businesswire.com
ATEC to Report Third Quarter 2026 Financial Results on October 29, 2026CARLSBAD, Calif--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report third quarter 2026 financial results on October 29, 2026, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET.WebcastTo access the live webcast, please use this link or visit the Events & Presentations section of ATEC's Investor Relations web.
2 months ago · businesswire.com
ATEC Appoints Tommy Carls Executive Vice President, Data Intelligence and StrategyCARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced that Thomas "Tommy" Carls has joined the company as Executive Vice President, Data Intelligence and Strategy. Carls will report directly to Chairman and Chief Executive Officer, Pat Miles, and will serve as a member of ATEC's Senior Leadership Team. In this newly created role, Carls will lead ATEC'.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove ATEC